Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer

被引:102
作者
Kim, Jin C.
Takahashi, Keiichi
Yu, Chang S.
Kim, Hee C.
Kim, Tae W.
Ryu, Min H.
Kim, Jong H.
Mori, Takeo
机构
[1] Univ Ulsan, Dept Surg, Coll Med, Seoul 138736, South Korea
[2] Univ Ulsan, Dept Med, Coll Med, Seoul 138736, South Korea
[3] Univ Ulsan, Dept Radiat Oncol, Coll Med, Seoul 138736, South Korea
[4] Asan Med Ctr, Seoul 138736, South Korea
[5] Tokyo Metropolitan Komagone Hosp, Dept Surg, Tokyo, Japan
关键词
D O I
10.1097/SLA.0b013e318070d587
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To evaluate comparative outcome between adjuvant postoperative chemoradiotherapy (postoperative CRT) and lateral pelvic lymph node dissection (LPLD) following total mesorectal excision (TME) in rectal cancer patients. Background: Although TME results in lower rate of locoregional recurrence compared with conventional surgery, these 2 treatment modalities following TME have not adequately been appraised until the present trend of preoperative chemoradiotherapy. Patients and Methods: Between 1995 and 2000, patients with stage II and III rectal cancer underwent TME plus postoperative CRT (n = 309) or LPLD (n = 176). Patients in the postoperative CRT group received 8 cycles of 5-fluorouracil plus leucovorin and 45 Gy pelvic radiotherapy. Patients in the LPLD group underwent lateral lymph node dissection outside the pelvic plexus. Results: The 5-year overall and disease-free survival rates were 78.3% and 67.3% in the postoperative CRT group, respectively, and 73.9% and 68.6% in the LPLD group, respectively, without significant differences between these groups. Patients in the LPLD group with stage III lower rectal cancer had a locoregional recurrence rate 2.2-fold greater than those in the postoperative CRT group (16.7% vs. 7.5%, P = 0.044). Multivariate analysis showed that APR and advanced T-category (T4) were significantly associated with locoregional recurrence, whereas lymph node metastases, high preoperative serum carcinoembryonic antigen, and APR were significantly associated with shortening of disease-free survival. Conclusions: Postoperative-CRT and LPLD following TME resulted in comparable survival rates, but the locoregional recurrence rate was higher in the LPLD group. These findings suggest that initial surgery is appropriate for rectal cancer patients who are candidates for low anterior resection without extensive local disease (T1-T3), regardless of lymph node status.
引用
收藏
页码:754 / 762
页数:9
相关论文
共 33 条
[1]
LOCAL RECURRENCE OF COLORECTAL-CANCER - THE PROBLEM, MECHANISMS, MANAGEMENT AND ADJUVANT THERAPY [J].
ABULAFI, AM ;
WILLIAMS, NS .
BRITISH JOURNAL OF SURGERY, 1994, 81 (01) :7-19
[2]
Alberts J C J, 2003, Colorectal Dis, V5, P478, DOI 10.1046/j.1463-1318.2003.00515.x
[3]
[Anonymous], 1985, NEW ENGL J MED, V312, P1465
[4]
Adjuvant radiation for rectal cancer: Do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States [J].
Baxter, NN ;
Rothenberger, DA ;
Morris, AM ;
Bullard, KM .
DISEASES OF THE COLON & RECTUM, 2005, 48 (01) :9-15
[5]
Chemotherapy with preoperative radiotherapy in rectal cancer [J].
Bosset, Jean-Francois ;
Collette, Laurence ;
Calais, Gilles ;
Mineur, Laurent ;
Maingon, Philippe ;
Radosevic-Jelic, Ljiljana ;
Daban, Alain ;
Bardet, Etienne ;
Beny, Alexander ;
Ollier, Jean-Claude .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11) :1114-1123
[6]
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results - EORTC 22921 [J].
Bosset, JF ;
Calais, G ;
Mineur, L ;
Maingon, P ;
Radosevic-Jelic, L ;
Daban, A ;
Bardet, E ;
Beny, A ;
Briffaux, A ;
Collette, L .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5620-5627
[7]
Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: A final report [J].
Cafiero, F ;
Gipponi, M ;
Lionetto, R .
JOURNAL OF SURGICAL ONCOLOGY, 2003, 83 (03) :140-146
[8]
Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision [J].
Colquhoun, P ;
Wexner, SD ;
Cohen, A .
JOURNAL OF SURGICAL ONCOLOGY, 2003, 83 (03) :133-139
[9]
Preoperative irradiation affects the functional results after surgery for rectal cancer:: Results from a randomized study -: Reply [J].
Dahlberg, M ;
Glimelius, B ;
Graf, W ;
Påhlman, L .
DISEASES OF THE COLON & RECTUM, 1998, 41 (05) :550-551
[10]
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer [J].
Das, P ;
Skibber, JM ;
Rodriguez-Bigas, MA ;
Feig, BW ;
Chang, GJ ;
Hoff, PM ;
Eng, C ;
Wolff, RA ;
JanJan, NA ;
Delclos, ME ;
Krishnan, S ;
Levy, LB ;
Ellis, LM ;
Crane, CH .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (03) :219-224